BioAdvance News NuPathe Portfolio News

FDA is Readying to Rule on NuPathe’s Revised Application for its Patch to Treat Migraines

By WebmasterJanuary 14, 2013November 1st, 2024No Comments

FDA is Readying to Rule on NuPathe’s Revised Application for its Patch to Treat Migraines
Read more here

Previous PostInfraScan Receives FDA Approval of Next Generation, Noninvasive Handheld Brain Hematoma Detector
Next PostUniversity City Science Center Deciding Factor in Tech Firm's Move to Philadelphia